Cellular taxonomy of the preleukemic bone marrow niche of acute myeloid leukemia

急性髓系白血病前白血病骨髓微环境的细胞分类学

阅读:2
作者:Chinmayee Goda # ,Rohan Kulkarni # ,Yaphet Bustos ,Wenjun Li ,Alexander Rudich ,Ozlen Balcioglu ,Sadie Chidester ,Amog P Urs ,Malith Karunasiri ,Yzen Al-Marrawi ,Erin Korn ,Sanjay Kanna ,Elizabeth A R Garfinkle ,Nisarg Shah ,Ashley Wooten ,Bethany Mundy-Bosse ,Lalit Sehgal ,Bin Zhang ,Guido Marcucci ,Elaine R Mardis ,Ramiro Garzon ,Robert L Bowman ,Aaron D Viny ,Linde A Miles ,Katherine E Miller ,Adrienne M Dorrance

Abstract

Leukemias arise from recurrent clonal mutations in hematopoietic stem/progenitor cells (HSPCs) that cause profound changes in the bone marrow microenvironment (BMM) favoring leukemic stem cell (LSC) growth over normal HSPCs. Understanding the cross talk between preleukemic mutated HSPCs and the BMM is critical to develop novel therapeutic strategies to prevent leukemogenesis. We hypothesize that preleukemic-LSCs (pLSCs) induce BMM changes critical for leukemogenesis. Using our AML-murine model, we performed single-cell RNA-sequencing of preleukemic BMM (pBMM) cells. We found normal HSC (nHSC)-regulating LepR+ mesenchymal stem cells, and endothelial cells were decreased, along with increases in CD55+ fibroblasts and pericytes. Preleukemic CD55+ fibroblasts had higher proliferation rates and decreased collagen expression, suggesting extracellular matrix remodeling during leukemogenesis. Importantly, co-culture assays found preleukemic CD55+ fibroblasts expanded pLSCs significantly over nHSCs. In conclusion, we have identified a distinct pBMM and a novel CD55+ fibroblast population that is expanded in pBMM that promote fitness of pLSCs over nHSCs.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。